a maximum of $30 mill. InSitu Biologics InSitu Biologics is an emerging ... overdose. InSitu is focused on providing a solution to these problems. InSitu has ...
Analgesic. Limited opportunity to invest in InSitu Biologics' AnestaGel™, ... from InSitu Biologics, in the sequence that your reservation was made. ...
investment $500. InSitu Biologics - Closing soon. Emerging Biotech company focusing ... non-opiate, non-addictive painkiller. The InSitu Biologics offer is closing soon. Minimum ...
and improvements Check out Golf Suites 1 InSitu Biologics - Anyone can invest ... on November 30, 2019 Check out InSitu Exclusive offerings only for Accredited ...
$1.7 million in a short period. InSitu Biologics is accepting a limited amount of investments at $6.85 per share. Check out InSitu View ... kosb95_17756's blog InSitu Bi ologics - AnestaGel™- ...
in InSitu Biologics' AnestaGel™, a patented non-opioid pain relief drug ... will then receive a private invitation to invest from InSitu Biologics ...
unit price. Insitu Biologics Completed Their Raise to fund AnestaGel™, ...
in InSitu Biologics' AnestaGel™, a non-opioid pain relief drug based ...
investment $500. InSitu Biologics - Max raise $10mill. Anyone can invest ...
Ms. Keith has been a Chief Financial Officer for private and public ... Ms. Keith held a senior accounting role for a public company listed ... Reardon is Professor and Jud and Pat Harper Chair of Chemical and Biological ...
